Skip to main content
Signal8

D An Evelyn

SEC insider (Form 3/4/5 filer). CIK 0001325168. Director at Backblaze, Inc. (BLZE) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on May 26, 2026. Located in SAN FRANCISCO, CA.

Companies D An Evelyn has filed insider reports for

  • Backblaze, Inc. (BLZE): Director
  • Matinas BioPharma Holdings, Inc. (MTNB): Director
D An Evelyn profile photo

D An Evelyn

CIK: 0001325168

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Backblaze, Inc. logo
BLZE

Backblaze, Inc.

Director
Matinas BioPharma Holdings, Inc. logo
MTNB

Matinas BioPharma Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Backblaze, Inc. logo
    BLZE

    Backblaze, Inc.

    May 26, 2026
    Award
    Direct
    19.3K shares-
  • Backblaze, Inc. logo
    BLZE

    Backblaze, Inc.

    May 27, 2025
    Award
    Direct
    25.2K shares-
  • Matinas BioPharma Holdings, Inc. logo
    MTNB

    Matinas BioPharma Holdings, Inc.

    Apr 30, 2025
    Award

    Stock Option (right to Buy)

    Direct
    11.6K shares-

1-3 of 3